Sign In
Buy IVVD
$1.10
-0.0400 (-3.51%)
At Close: Jun 03, 2026
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
07:05am, Tuesday, 23'rd Dec 2025
NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an inv
NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced initiation of the DECLARATION trial evaluating VYD2311, an investigational vaccine-alternative monoclon
Pre-Market Stock Futures: Futures are trading higher as we get ready to start a holiday-shortened trading week after an outstanding triple-witching Friday rally that may have kicked the "Santa Claus"
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference
07:01am, Tuesday, 25'th Nov 2025
NEW HAVEN, Conn., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that management will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on
Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness
07:01am, Monday, 24'th Nov 2025
NEW HAVEN, Conn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced it has identified and nominated for preclinical development a potentially best-in-class monoclonal anti
Invivyd: Maintaining Hold Rating With VYD2311 Alternative To Covid-19 Vaccination
03:49pm, Tuesday, 18'th Nov 2025
Invivyd, Inc. remains a Hold rating as it advances its monoclonal antibody pipeline, notably VYD2311 as a Covid-19 vaccine alternative. VYD2311 offers broader patient coverage and intramuscular dosing
Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
08:23am, Tuesday, 18'th Nov 2025
U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Tuesday.
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
10:40pm, Monday, 17'th Nov 2025
NEW HAVEN, Conn., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced the pricing of an underwritten public offering of 44,000,000 shares of its common stock at an
Invivyd Announces Proposed Public Offering of Common Stock
04:01pm, Monday, 17'th Nov 2025
NEW HAVEN, Conn., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced that it has commenced an underwritten public offering of shares of its common stock. In addit
Invivyd (NASDAQ:IVVD) Reaches New 1-Year High – Time to Buy?
03:38am, Monday, 17'th Nov 2025
Invivyd, Inc. (NASDAQ: IVVD - Get Free Report) hit a new 52-week high during mid-day trading on Saturday. The stock traded as high as $2.76 and last traded at $2.35, with a volume of 136241658 shares
Invivyd Target of Unusually High Options Trading (NASDAQ:IVVD)
02:19am, Saturday, 15'th Nov 2025
Invivyd, Inc. (NASDAQ: IVVD - Get Free Report) was the recipient of some unusual options trading activity on Friday. Stock investors purchased 2,953 call options on the company. This is an increase of
Invivyd, Inc. (IVVD) Q3 2025 Earnings Call Transcript
11:36am, Thursday, 06'th Nov 2025
Invivyd, Inc. ( IVVD ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Katie Falzone Marc Elia Timothy Lee - Chief Commercial Officer William Duke - CFO, Principal Accounting O
Invivyd, Inc. (IVVD) Reports Q3 Loss, Lags Revenue Estimates
10:16am, Thursday, 06'th Nov 2025
Invivyd, Inc. (IVVD) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.51 per share a year ago.
Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights
07:01am, Thursday, 06'th Nov 2025
NEW HAVEN, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced financial results for the quarter ended September 30, 2025, and provided recent business highlights.
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025
04:01pm, Monday, 03'rd Nov 2025
NEW HAVEN, Conn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company focused on delivering protection from serious viral infectious diseases, today announced t
